EDAP

$4.06

Post-MarketAs of Mar 17, 8:00 PM UTC

EDAP TMS S.A., together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally.

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$4.06
Potential Upside
5%
Whystock Fair Value$4.26
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Distribution

EDAP TMS S.A., together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally. The ...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$151.81M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
-0.17
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-59.52%
Quick Ratio
Tight liquidity. Monitor cash flow carefully against debt.
0.94

Recent News

MT Newswires
Mar 13, 2026

European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading

European equities traded in the US as American depositary receipts were lower late Friday morning, d

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Zacks
Mar 9, 2026

ClearPoint Neuro (CLPT) Moves 8.1% Higher: Will This Strength Last?

ClearPoint Neuro (CLPT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MT Newswires
Mar 6, 2026

European Equities Traded in the US as American Depositary Receipts Fall in Friday Trading; Down 5% for Week

European equities traded in the US as American depositary receipts were down sharply late Friday mor

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
MT Newswires
Mar 2, 2026

European Equities Traded in the US as American Depositary Receipts Tumble in Monday Trading

European equities traded in the US as American depositary receipts were falling sharply late Monday

BEARISH
Negative press. News cycle fixated on risk factors or misses.
MT Newswires
Feb 11, 2026

European Equities Traded in the US as American Depositary Receipts Slightly Higher in Wednesday Trading

European equities traded in the US as American depositary receipts were modestly higher late Wednesd

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.